Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

MRC WIMM were honoured to host a celebration marking this year’s Nobel Prize in Physiology or Medicine, awarded to their alumnus Sir Peter Ratcliffe.

“How is it that I came to be in this rather fortunate position” were the opening words by Sir Peter Ratcliffe, winner of this year’s Nobel Prize in Physiology or Medicine. The speech was part of a celebration hosted at the MRC WIMM on Monday 21 October, the anniversary of Alfred Nobel’s birth.

Attended by over 300 people, the party was an opportunity to celebrate Sir Peter Ratcliffe’s achievements, not only scientific but also his efforts to support and foster the scientific and medical community in Oxford. Sir John Bell, Regius Professor of Medicine at the University of Oxford, thanked Sir Peter for his contributions over the years to the Medical School, the MRC WIMM and the Nuffield Department of Medicine, and lauded him as a “real clinician scientist”. These sentiments were echoed by Prof Richard Cornall, Head of the Nuffield Department of Medicine, a position previously occupied by Sir Peter.

Read more (MRC WIMM website)

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.